Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 1;6(3):919-24.
doi: 10.14661/2014.919-924. eCollection 2014 Jul-Sep.

In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran

Shahin Najar Peerayeh  1 , Afsaneh Karmostaji  2 , Soraya Sharifi Sarasiabi  3 , Sedigheh Javadpour  4 , Parivash Davoodian  5 , Nahid Moradi  6
Affiliations

In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran

Shahin Najar Peerayeh et al. Electron Physician. .

Abstract

Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of the main causes of nosocomial infections in recent years. The high prevalence of drug resistance in A. baumannii limits the therapeutic options for treating infections caused by these bacteria. The objective of this study was to determine the in vitro activity of Tigecycline and Colistin against clinical isolates of A. baumannii in Tehran and Bandar Abbas, Iran.

Methods: This study was conducted from March 2009 to November 2010 at three hospitals in Tehran and Bandar Abbas, Iran, using 165 Acinetobacter species isolated from clinical specimens. All isolates were subjected to PCR to detect bla OXA-51-like genes that are unique to Acinetobacter baumannii. Isolates that gave a band for the bla OXA-51-like genes were identified as A. baumannii. Anti-microbial susceptibility tests were performed for Tigecycline, Colistin, and other antibiotics.

Results: Sensitivity rates to Colistin and Polymyxin-B were 100%. Resistance rates for Tigecycline were 4.2% in Tehran and 8.8% in Bandar-Abbas according to Jones criteria, whereas, according to U.S. FDA criteria, the resistance rates were 20.8% and 17.6%, respectively.

Conclusions: New alternative drugs are needed for the treatment of drug resistant A. baumannii. Although Colistin appears to be a good choice, adverse reactions have limited its usage. Tigecycline is effective against A. baumannii isolates, and it shows promise for solving the problem.

Keywords: Acinetobacter baumannii; Polymyxin-B, Colistin; Tigecycline.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Polymerase chain reaction bla –oxa-51 like gene (353 bp), line1:100-bp ladder, line 8: positive control, line 7: negative control and lines 2–6 subjects
See this image and copyright information in PMC

References

    1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clinical microbiology reviews. 2008;21(3):538–82. doi: 10.1128/CMR.00058-07. Epub 2008/07/16. URL: http://dx.doi.org/10.1128/CMR.00058-07. - DOI - DOI - PMC - PubMed
    1. Tan TY, Ng LS, Poh K. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2. Diagnostic microbiology and infectious disease. 2007;58(3):357–61. doi: 10.1016/j.diagmicrobio.2007.02.008. Epub 2007/05/01. URL: http://dx.doi.org/10.1016/j.diagmicrobio.2007.02.008. - DOI - DOI - PubMed
    1. Dizbay M, Altuncekic A, Sezer BE, Ozdemir K, Arman D. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. International Journal of Antimicrobial Agents. 2008;32(1):29–32. DOI: v. URL: http://dx.doi.org/http://dx.doi.org/10.1016/j.ijantimicag.2008.02.016. - DOI - PubMed
    1. Park YK, Choi JY, Shin D, Ko KS. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. International Journal of Antimicrobial Agents. 2011;37(6):525–30. doi: 10.1016/j.ijantimicag.2011.02.008. URL: http://dx.doi.org/http://dx.doi.org/10.1016/j.ijantimicag.2011.02.008. - DOI - DOI - PubMed
    1. Wang YF, Dowzicky MJ. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Diagnostic microbiology and infectious disease. 2010;68(1):73–9. Epub 2010/08/24. DOI: v. URL: http://dx.doi.org/10.1016/j.diagmicrobio.2010.04.002. - DOI - PubMed

LinkOut - more resources